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. (A) Heart rate trend during an auto-activated event recorded by the implantable loop recorder. (B) Electrocardiogram showing a transient increase in heart rate followed by a gradual decrease, culminating in 18-s asystole.
IMAGES IN CARDIOVASCULAR MEDICINE Syncope and Ictal Asystole
ally resulting in traumatic injury. His wife observed that he briefly became pale and unresponsive during these times, in the absence of automatic or tonic-clonic movements, and promptly regained consciousness thereafter. He had no family history of epilepsy. General physical and neurologic examinations, including orthostatic vital signs, and computed tomography of the head, were normal. A 12-lead electrocardiogram (ECG) showed sinus rhythm at a rate of 72 beats/min, complete right bundle branch block and left posterior fascicular block. Cardiac investigations including transthoracic echocardiography, ambulatory ECG monitoring, chest radiography, and treadmill exercise testing were all normal. A head-up tilt test at 80º for 30 min was negative. Because the patient had recurrent unexplained syncope in presence of an abnormal ECG, he underwent implantation, in accordance with the guidelines issued by the European Society of Cardiology, 1 of a Reveal ® DX 9528 loop recorder (ILR; Medtronic, Minneapolis, MN, USA).
The patient experienced 3 syncopal episodes during the 3 months following ILR implantation. The ECG during syncope monitored with ILR showed first an increase, then a gradual decrease in heart rate, ending with sinus bradycardia at a rate of 30-40 beats/min for 10 s. In addition, 27 nocturnal, asymptomatic events were recorded automatically. All recordings showed first an increase, then a gradual decrease in heart rate, ending with profound bradycardia or asystole lasting up to 18 s (Figure 1) . A sleep disorder was excluded on normal polysomnography. The patient then underwent a 16-channel electroencephalogram (EEG), using the 10-20 international system, which showed interictal epileptiform discharges over both anterior temporal regions (Figure 2) . The patient was diagnosed with temporal lobe epilepsy (TLE), associated with ictal bradycardia and asystole. His symptoms disappeared after initiation of oral carbamazepine at 100 mg daily, although the ILR continued to record asymptomatic nocturnal bradycardia and asystole. After the carbamazepine was increased to 200 mg/day, no further episodes of bradycardia or asystole were recorded and no recurrence of syncope was observed during 9 months of follow-up.
Although epilepsy and reflex syncope can both cause a transient loss of consciousness and, on occasion, share prodromes, the pathophysiological mechanisms underlying these 2 clinical entities are very different. Syncope is caused by transient global cerebral hypoperfusion, while epilepsy is caused by abnormal electrical activity of the brain without global cerebral hypoperfusion. Marked fluctuations in heart rate, well-documented in patients with reflex syncope, may also occur in patients with seizure disorders, with ictal bradycardia, asystole or both observed in up to 0.27% of all patients with epilepsy. 2 In addition, typical signs of TLE, such as motionless staring, automatic movements of the hands or mouth, communication disorders, abnormal speech or behavior, are not always present and were not observed in the present patient, blurring the distinction between syncope and TLE.
ILR are used in the investigations of unexplained syncope, and may also help diagnose generalized tonic-clonic seizures as a cause of recurrent, unexplained episodes of loss of consciousness. Myopotential noise during convulsion have been clearly demonstrated using ILR in patients with generalized tonic-clonic seizure in previous reports. 3, 4 In the present case, ictal asystole, without myopotential noise, was demonstrated with ILR as a complex partial seizure of typical TLE. Furthermore, bradyarrhythmias requiring permanent pacing were documented in 20% of epileptic patients monitored with an ILR, 5 suggesting a relationship with the syndrome of sudden unexpected death, which affects approximately 7-17% of the epileptic population, 6 or an estimated 0.12% of epilepsy patients per year. 5 The contribution of cardiac pacing in the therapy of ictal bradycardia/asystole associated with TLE remains controversial. 7-11 Earlier studies have found permanent pacing effective 7-9 or ineffective. 10, 11 Schuele et al reported similar changes in heart rate and duration of asystole during clinical events in patients presenting with ictal bradycardia/asystole versus neurally mediated reflex syncope, suggesting that both are mediated by a mechanism involving medullary reflex centers and a transient increase in vagal tone. 2 In multicenter randomized studies, permanent pacing was ineffective in patients presenting with neurally mediated reflex syncope. 12,13 Therefore, it may also be ineffective in patients with syncope induced by ictal bradycardia/asystole. The present patient was treated with carbamazepine alone and remained free from syncope and ictal bradycardia/asystole during 9 months of follow-up. After the dose of carbamazepine was increased to 200 mg/day, neither syncope nor the nocturnal asystole was confirmed. In addition, interictal EEG spikes had disappeared. In daily clinical practice, most patients with TLE are usually confirmed to have interictal EEG spikes without the clinical seizure. Although we could not record EEG simultaneously during the asystole, a history suggesting temporal lobe seizure and the presence of interictal spikes strongly indicated a diagnosis of TLE. Furthermore, the complete abolishment of asystole by the anti-epileptic medication (carbamazepine) further confirmed that asystole was caused by the seizure activities.
In conclusion, TLE, typically manifesting as complex partial seizure without convulsions, may be associated with ictal bradycardia/asystole, and may not be detected as the cause of syncope. ILR is a reliable means of diagnosing ictal bradyarrhythmias, which may be similar to those observed in patients with neurally mediated reflex syncope, 14,15 even asymptomatic. Anti-epileptic drug therapy is likely to be effective in epilepsy patients presenting with syncope.
